Reunion Neuroscience (REUN) Stock Analysis

What Reunion Neuroscience does

Field Trip Health Ltd. is a North American company specializing in the development and delivery of psychedelic-assisted therapies. The organization operates Field Trip Health Centres, which offer psychedelic-based treatments, and provides digital applications under the Field Trip brand. Additionally, its Field Trip Discovery division focuses on researching and creating next-generation psychedelic molecules. The company also administers ketamine-assisted therapy to address various conditions, including depression, anxiety, and addiction. Established in 2008, Field Trip Health Ltd. is based in Toronto, Canada.

Key metrics

ETFs linked to REUN

Broad-market and Healthcare sector ETFs an investor holding Reunion Neuroscience is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how REUN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Reunion Neuroscience?

Reunion Neuroscience trades under the ticker REUN on NASDAQ.

Which exchange is REUN listed on?

REUN is listed on NASDAQ.

What sector does Reunion Neuroscience operate in?

Reunion Neuroscience is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze REUN in a portfolio?

PortView shows REUN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.